Mechanism of dinitrochlorobenzene-induced dermatitis in mice: Role of specific antibodies in pathogenesis

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Zhang, Elizabeth Yan ^a   Chen, Aaron Yun ^a   Zhu, Bao Ting ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ANTIBODY; CYTOKINE; IRRITANT AGENT;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATITIS; EXPERIMENTAL DESIGN; FEMALE; HYPERSENSITIVITY REACTION; IMMUNOPATHOGENESIS; MALE; MOUSE; NONHUMAN; TH1 CELL; TH2 CELL; ANIMAL; C57BL MOUSE; DRUG EFFECT; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PATHOLOGY; SKIN; SKIN ALLERGY;

ANIMALIA; MUS;

ANIMALS; ANTIBODIES; B-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; DINITROCHLOROBENZENE; FEMALE; IMMUNITY, CELLULAR; IRRITANTS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; SKIN; TH1 CELLS; TH2 CELLS;

EID: 70450175709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007703     Document Type: Article

References (34)

1. Garrigue JL, Nicolas JF, Fraginals R, Benezra C, Bour H, et al. (1994) Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers. Contact Dermatitis 30: 231-237.
2. Watanabe H, Unger M, Tuvel B, Wang B, Sauder DN (2002) Contact hypersensitivity: the mechanism of immune responses and T cell balance. J Interferon Cytokine Res 22: 407-412.
3. Grabbe S, Schwarz T (1998) Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 19: 37-44.
4. Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, et al. (2007) Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest 117: 1381-1390.
5. Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, et al. (1999) Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J Exp Med 189: 779-786.
6. Xu H, Banerjee A, Dilulio NA, Fairchild RL (1997) Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells. J Immunol 158: 4721-4728.
7. Wang B, Fujisawa H, Zhuang L, Freed I, Howell BG, et al. (2000) CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J Immunol 165: 6783-6790.
8. Larsen JM, Geisler C, Nielsen MW, Boding L, Von Essen M, et al. (2007) Cellular dynamics in the draining lymph nodes during sensitization and elicitation phases of contact hypersensitivity. Contact Dermatitis 57: 300-308.
9. Watanabe R, Fujimoto M, Ishiura N, Kuwano Y, Nakashima H, et al. (2007) CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol 171: 560-570.
10. Askenase PW (2001) Yes T cells, but three different T cells (alphabeta, gammadelta and NK T cells), and also B-1 cells mediate contact sensitivity. Clin Exp Immunol 125: 345-350.
11. Campos RA, Szczepanik M, Itakura A, Lisbonne M, Dey N, et al. (2006) Interleukin-4-dependent innate collaboration between iNKT cells and B-1 B cells controls adaptative contact sensitivity. Immunology 117: 536-547.
12. Fei M, Wu X, Xu Q (2005) Astilbin inhibits contact hypersensitivity through negative cytokine regulation distinct from cyclosporin A. J Allergy Clin Immunol 116: 1350-1356.
13. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH (2006) T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 7: 507-516.
14. Perone MJ, Bertera S, Shufesky WJ, Divito SJ, Montecalvo A, et al. (2009) Suppression of autoimmune diabetes by soluble galectin-1. J Immunol 182: 2641-2653.
15. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164: 6166-6173.
16. Hsieh CS, Macatonia SE, O'Garra A, Murphy KM (1995) T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 181: 713-721.
17. Wang B, Feliciani C, Freed I, Cai Q, Sauder DN (2001) Insights into molecular mechanisms of contact hypersensitivity gained from gene knockout studies. J Leukoc Biol 70: 185-191.
18. Traidl C, Jugert F, Krieg T, Merk H, Hunzelmann N (1999) Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J Invest Dermatol 112: 476-482.
19. Leung DY (1995) Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 96: 302-318; quiz 319.
20. Nagai J, Yano I, Hashimoto Y, Takano M, Inui K (1998) Efflux of intracellular alpha-ketoglutarate via p-aminohippurate/dicarboxylate exchange in OK kidney epithelial cells. J Pharmacol Exp Ther 285: 422-427.
21. Nagai H, Ueda Y, Tanaka H, Hirano Y, Nakamura N, et al. (1999) Effect of overproduction of interleukin 5 on dinitrofluorobenzene-induced allergic cutaneous response in mice. J Pharmacol Exp Ther 288: 43-50.
22. Weigmann B, Schwing J, Huber H, Ross R, Mossmann H, et al. (1997) Diminished contact hypersensitivity response in IL-4 deficient mice at a late phase of the elicitation reaction. Scand J Immunol 45: 308-314.
23. Yokozeki H, Ghoreishi M, Takagawa S, Takayama K, Satoh T, et al. (2000) Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med 191: 995-1004.
24. Thomson JA, Troutt AB, Kelso A (1993) Contact sensitization to oxazolone: involvement of both interferon-gamma and interleukin-4 in oxazolone-specific Ig and T-cell responses. Immunology 78: 185-192.
25. Stevens TL, Bossie A, Sanders VM, Fernandez-Botran R, Coffman RL, et al. (1988) Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334: 255-258.
26. Miles SA, Conrad SM, Alves RG, Jeronimo SM, Mosser DM (2005) A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J Exp Med 201: 747-754.
27. Cohen S, Ward PA (1971) In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils. J Exp Med 133: 133-146.
28. Yamada N, Wakugawa M, Kuwata S, Yoshida T, Nakagawa H (1995) Chronologic analysis of in situ cytokine expression in mite allergen-induced dermatitis in atopic subjects. J Allergy Clin Immunol 96: 1069-1075.
29. Wang LF, Sun CC, Wu JT, Lin RH (1999) Epicutaneous administration of hapten through patch application augments TH2 responses which can downregulate the elicitation of murine contact hypersensitivity. Clin Exp Allergy 29: 271-279.
30. Nakazawa M, Sugi N, Kawaguchi H, Ishii N, Nakajima H, et al. (1997) Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J Allergy Clin Immunol 99: 673-682.
31. Shaala AY, Hodgson C, Ling NR, Jefferis R (1980) B lymphocytes in contact dermatitis. Br J Dermatol 103: 159-165.
32. Carapeto FJ, Winkelmann RK, Jordon RE (1976) T and B lymphocytes in contact and atopic dermatitis. Arch Dermatol 112: 1095-1100.
33. Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, et al. (1997) Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 159: 2484-2491.
34. Warbrick EV, Dearman RJ, Kimber I (2002) Induced changes in total serum IgE concentration in the Brown Norway rat: potential for identification of chemical respiratory allergens. J Appl Toxicol 22: 1-11.